ERK1/2 및 SHP2 억제제 조합 요법

본 개시내용은 일반적으로 암, 구체적으로, 고형 종양을 치료하기 위한 SHP2 억제제와 함께 조합된 ERK1/2 억제제의 용도에 관한 것이다. The present disclosure relates generally to the use an ERK1/2 inhibitor in combination with a SHP2 inhibitor for treating cancer, specifically solid tumors....

Full description

Saved in:
Bibliographic Details
Main Authors LIN WEI, OH JOANNE, SHOEMAKER ROBERT FIELD, BRAIL LESLIE HARRIS, MARTIN LEENUS, LEW ERIN DENISE, ZHANG JINGCHUAN
Format Patent
LanguageKorean
Published 26.06.2024
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:본 개시내용은 일반적으로 암, 구체적으로, 고형 종양을 치료하기 위한 SHP2 억제제와 함께 조합된 ERK1/2 억제제의 용도에 관한 것이다. The present disclosure relates generally to the use an ERK1/2 inhibitor in combination with a SHP2 inhibitor for treating cancer, specifically solid tumors.
Bibliography:Application Number: KR20247002544